Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

No phase data

Trial Status

Other1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

Reactogenicity, Immunogenicity and Inflammatory Response by New COVID-19 Vaccine Platforms
COVID-19 VaccinationInflammationVaccine Adverse Reaction+1 more
PrincipalinvestigatorStart date: 2021-03-01

Research Network

Collaboration Network

3 collaborators·3 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Ajou University School of Medicine

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Yu Bin Seo, MD

Hallym University Kangnam Sacred Heart Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

COVID-19 VaccinationInflammationVaccine Adverse Reaction+1 more

Worked with same sponsors:

Ajou University School of MedicineHallym University Kangnam Sacred Heart Hospital+2 more
Collaborated on 1 trial
Similarity Score44%

Joon Young Song, MD

Korea University Guro Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

COVID-19 VaccinationInflammationVaccine Adverse Reaction+1 more

Worked with same sponsors:

Ajou University School of MedicineHallym University Kangnam Sacred Heart Hospital+2 more
Collaborated on 1 trial
Similarity Score44%

Zhaoping Li, MD, PhD

University of California, Los Angeles

Related
17 trials

Shared therapeutic areas:

Inflammation
Similarity Score8%

Joel Neutel, MD

Orange County Research Center

Related
11 trials

Shared therapeutic areas:

Inflammation
Similarity Score8%

Ronald M Krauss, MD

UCSF Benioff Children's Hospital Oakland

Related
8 trials

Shared therapeutic areas:

Inflammation
Similarity Score8%

Stavros Stavrakis, MD

University of Oklahoma

Related
7 trials

Shared therapeutic areas:

Inflammation
Similarity Score8%

Wayne W Campbell, Ph.D.

Purdue University

Related
9 trials

Shared therapeutic areas:

Inflammation
Similarity Score8%

Adriana R Marques, M.D.

National Institute of Allergy and Infectious Diseases (NIAID)

Related
10 trials

Shared therapeutic areas:

Inflammation
Similarity Score8%

David C Nieman, DrPH

Appalachian State Univ

Related
11 trials

Shared therapeutic areas:

Inflammation
Similarity Score8%

Kong Y Chen, Ph.D.

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Related
11 trials

Shared therapeutic areas:

Inflammation
Similarity Score8%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT05315856PrincipalInvestigator

Reactogenicity, Immunogenicity and Inflammatory Response by New COVID-19 Vaccine Platforms

COVID-19 VaccinationInflammationVaccine Adverse Reaction+1 more
Unknown

All 1 trials loaded